These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38771189)

  • 1. A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J
    Addiction; 2024 Sep; 119(9):1564-1571. PubMed ID: 38771189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
    Leonard JB; Anderson B; Klein-Schwartz W
    J Psychopharmacol; 2018 Dec; 32(12):1286-1294. PubMed ID: 30182795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
    Ezeaka UC; Kim HJJ; Laprairie RB
    Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
    Whelan A; Johnson MI
    Pain Manag; 2018 May; 8(3):217-229. PubMed ID: 29722608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of cluster headache to psilocybin and LSD.
    Sewell RA; Halpern JH; Pope HG
    Neurology; 2006 Jun; 66(12):1920-2. PubMed ID: 16801660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
    KANDIC B; DORDEVIC D
    Vojnosanit Pregl; 1963 May; 20():275-9. PubMed ID: 14067329
    [No Abstract]   [Full Text] [Related]  

  • 8. Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
    Keyes KM; Patrick ME
    Addiction; 2023 Dec; 118(12):2449-2454. PubMed ID: 37287110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of lysergic acid diethylamide (LSD) poisonings following insufflation of a white powder sold as cocaine.
    Roberts DM; Premachandra KH; Chan BS; Auld R; Jiranantakan T; Ewers C; McDonald C; Shaw V; Brown JA
    Clin Toxicol (Phila); 2021 Nov; 59(11):969-974. PubMed ID: 33849370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.
    ABRAMSON HA; GETTNER HH; ROLO A; DEAN G
    J Psychol; 1963 Oct; 56():363-74. PubMed ID: 14051981
    [No Abstract]   [Full Text] [Related]  

  • 11. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
    Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
    J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
    Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
    J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].
    MIYOSHI A
    Seishin Shinkeigaku Zasshi; 1964 Oct; 66():826-36. PubMed ID: 14286595
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 16. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
    Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.
    Müller F; Kraus E; Holze F; Becker A; Ley L; Schmid Y; Vizeli P; Liechti ME; Borgwardt S
    Psychopharmacology (Berl); 2022 Jun; 239(6):1933-1943. PubMed ID: 35076721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 20. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.